Intratympanic lidocaine instillation for Meniere's disease

被引:0
|
作者
Verdonck, J. [1 ]
Desloovere, C. [1 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Otorhinolaryngol Head & Neck Surg, B-3000 Louvain, Belgium
来源
B-ENT | 2011年 / 7卷 / 03期
关键词
Meniere's disease; vertigo; lidocaine; treatment; labyrinth anaesthesia; VESTIBULAR NERVE-SECTION; GENTAMICIN; TINNITUS; RATS;
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Intratympanic lidocaine instillation for Meniere's disease. Objectives: We studied the role of intratympanic lidocaine instillation as part of the treatment for vertigo in Meniere's disease. Methodology: We retrospectively analyzed 40 patients who underwent 74 labyrinth anaesthesias in our center between 1996 and 2006. We studied the attack-free period after instillation, the effect of repetitive procedures and the efficacy according to the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) (1995) criteria. Results: Labyrinth anaesthesia was effective in 70% of the studied procedures. If effective, the mean duration of the attack-free period was 12.6 months. Repetition was effective in 80.7% of the procedures if the previous procedure was effective as well. Two years after treatment 21 patients had AAO-HNS functional levels of 1 or 2 and 23 patients were class A or B. Conclusion: Labyrinth anaesthesia is an effective treatment for Meniere's disease and a useful tool for the control of symptoms. Repetitive instillation is effective especially when the previous instillation was also effective.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [21] Vestibular nerve section versus intratympanic gentamicin for Meniere's disease
    Hillman, TA
    Chen, DA
    Arriaga, MA
    LARYNGOSCOPE, 2004, 114 (02) : 216 - +
  • [22] Intratympanic gentamicin in Meniere's disease: our experience
    Perez Delgado, L.
    Fraile Rodrigo, J.
    Astier Pena, P.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2011, 125 (04) : 363 - 369
  • [23] Consensus on intratympanic drug delivery for Meniere's disease
    Li, Shuna
    Pyykko, Ilmari
    Zhang, Qing
    Yang, Jun
    Duan, Maoli
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (08) : 3795 - 3799
  • [24] Treatment of Meniere's disease by intratympanic gentamicin application
    Assimakopoulos, D
    Patrikakos, G
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2003, 117 (01) : 10 - 16
  • [25] Intratympanic gentamicin therapy for intractable Meniere's disease
    De Beer, Lieke
    Stokroos, Robert
    Kingma, Herman
    ACTA OTO-LARYNGOLOGICA, 2007, 127 (06) : 605 - 612
  • [26] Intratympanic gentamicin for treatment of intractable Meniere's disease: A preliminary report
    Rauch, SD
    Oas, JG
    LARYNGOSCOPE, 1997, 107 (01) : 49 - 55
  • [27] Intratympanic Dexamethasone in the Treatment of Meniere's Disease: A Comparison of Two Techniques
    Beyea, Jason A.
    Instrum, Ryan S.
    Agrawal, Sumit K.
    Parnes, Lorne S.
    OTOLOGY & NEUROTOLOGY, 2017, 38 (06) : E173 - E178
  • [28] Is low-dose intratympanic gentamicin an effective treatment for Meniere's disease: the Birmingham experience
    Watson, G. J.
    Nelson, C.
    Irving, R. M.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2015, 129 (10) : 970 - 973
  • [29] Intratympanic interval treatment for Meniere's disease
    Lange, G
    Mann, W
    Maurer, J
    HNO, 2003, 51 (11) : 898 - 902
  • [30] Hearing loss after intratympanic gentamicin therapy for unilateral Meniere's Disease
    Martin, E
    Perez, N
    OTOLOGY & NEUROTOLOGY, 2003, 24 (05) : 800 - 806